In 2013 Edward
Calabrese, a toxicologist from the University of Massachusetts, Amherst, and a
colleague were pining over century-old data on any evidence of whether low-dose
radiation therapy could be utilized to combat certain types of illness and
disease. Surprisingly, they did find proof that small amounts of radiation were
moderately effective in combating pneumonia.
The research showed
that doctors reported reduced symptoms within hours of a single dose of X-ray
exposure. At that time, only a few people noticed the findings from Calabrese,
and they were dismissed, only just being mentioned in a few publications.
However, that all changed when Covid-19 came around. People were rushing to
find any treatment that would prove even relatively effective against the novel
coronavirus, and its devastating pneumonia that is the hallmark of the disease.
“Back in February, I
started getting just dozens and dozens and dozens of emails from radiation
oncologists – people who treat cancer patients with targeted radiation. And
they had come across our paper, and they thought that this might be a vehicle
by which they could help suffering and dying COVID patients perhaps survive,”
Calabrese said. “Clinical trials are now going on across the country.”
At least a dozen
trials worldwide are being tested for low-dose radiation therapy (LDTR), as a
treatment to pneumonia related to Covid-19. The theory is that radiation to the
lungs will halt the runaway inflammation responsible for the devastating
pneumonia that leads to the course of some Covid-19 patients.
Acceletronics is an independent service company
dedicated to delivering the best equipment performance and reliability from
Linear Accelerators and CT Scanners across all major brands and models. We
provide premium customer experience throughout the USA with our team of highly
qualified oncology equipment and dedicated service specialists.
No comments:
Post a Comment